These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7491838)

  • 1. [Long-term hormone replacement and risk of breast carcinoma: current status. On behalf of the German Menopause Society and the Professional Society of Gynecologic Endocrinology and Reproductive Medicine of the German Society of Gynecology and Obstetrics].
    Kuhl H; Runnebaum B; Schneider HP
    Zentralbl Gynakol; 1995; 117(10):549-53. PubMed ID: 7491838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term hormone substitution and risk of breast carcinoma: current status].
    Kuhl H; Runnebaum B; Schneider HP
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):M1-5. PubMed ID: 8852790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone substitution in climacteric. Position of the German Menopause Society].
    Schneider HP; Kuhl H; Dören M; Hesch D
    Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postmenopausal hormone replacement therapy--is there a cause of worry?].
    Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormone replacement therapy in patients after breast cancer].
    Köninger A; Kümmel S; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
    [No Abstract]   [Full Text] [Related]  

  • 7. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
    Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens and progestins: what to use and how to use it.
    Jones KP
    Clin Obstet Gynecol; 1992 Dec; 35(4):871-83. PubMed ID: 1451370
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogens, progestins and breast proliferation.
    Thijssen JH
    Zentralbl Gynakol; 1997; 119 Suppl 2():43-7. PubMed ID: 9361394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestins and breast cancer risk.
    Campagnoli C; Biglia N; Giai M; Sismondi P
    Zentralbl Gynakol; 1997; 119 Suppl 2():38-42. PubMed ID: 9361393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hot confusion about estrogen and breast cancer].
    Ursin G
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2225. PubMed ID: 12426906
    [No Abstract]   [Full Text] [Related]  

  • 14. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 15. Women seek alternatives to hormone replacement therapy.
    Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic changes in different hormone replacement therapies in climacteric].
    Foth D; Römer T; Panzig E
    Zentralbl Gynakol; 1995; 117(7):349-52. PubMed ID: 7668064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status: hormone substitution and risk of endometrial carcinoma].
    Kuhl H
    Zentralbl Gynakol; 1997; 119(6):296-7. PubMed ID: 9312968
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.